Renalyse | A home healtcare platform
17134
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-17134,bridge-core-3.0.1,qodef-qi--no-touch,qi-addons-for-elementor-1.5.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-28.7,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.8.0,vc_responsive,elementor-default,elementor-kit-18639

Home analysis

Renalyse by CreatSens: A new low-cost technology able to determine the key kidney function indicators with only a drop of blood.

Data exchange

A technological platform to remotely monitor your health and increase efficiency of treatments.

Telehealth

Improved quality of life by a convenient stay-at-home analysis and real-time connection with the doctor.

CreatSens Health S.L. is a spin-off from

Universitat Rovira i Virgili (URV)

Founded in September 2017, in Tarragona (Spain), CreatSens work on improving the management of chronic kidney disease (CKD) by delivering diagnostic tools to help the healthcare system and better manage the information generated in the primary care centers, doctor’s office or patient’s home.

Renalyse by CreatSens, S.L.: Chronic kidney disease

Chronic kidney disease

Chronic Kidney Disease increases the risk of death, hospitalization and major vascular events by 2 to 5-fold, compared to people who have normal kidney function.

Renalyse by CreatSens, S.L.: Healthcare tool

Healthcare tool

Early monitoring diagnostics tools are decisive to reduce acute episodes and to increase the efficacy of treatments for CKD.

Renalyse by CreatSens, S.L.: Patient empowerment

Patient empowerment

Improved quality of life ensured by a convenient home analysis, enhanced relationship with the doctor, relevant medical information readily available through the cloud and personalized treatment.

12

% global population affected by Chronic Kidney Disease

200

million patients worldwide need a Renal Replacement Therapy (RRT)

75000

€ is what a RRT costs a year per patient

3

% of Healthcare budget per developed country

CreatSens participation at IQS NextTech Industrial Accelerator

The accelerator program provided a huge experience and key aspects for the industrial manufacturing from the prototype to the product. In the video, the CEO Adrià Maceira briefly explains the project and how great it was for our growth as a company to move to product development.

Need more info?